Skip to main content

Month: February 2021

Franklin Electric Reports Full Year 2020 Results and Record Fourth Quarter 2020 Results

Fourth Quarter 2020 HighlightsRecord sales of $321.1 millionOrganic sales growth for Distribution (21%) and Water Systems (4%)Gross profit margin as a percent of sales increased 300 basis pointsRecord GAAP operating income of $34.4 million, increasing 20% from the prior yearSuccessful completion of the Gicon Pumps and Equipment acquisition; expected to drive meaningful growth for DistributionFull Year 2020 HighlightsFull year 2020 Sales were $1,247.3 million.GAAP earnings per share of $2.14, a 5% increase from the prior yearFull year 2020 cash flow from operating activities was a record of $212 million and free cash flow conversion of net income was 187%FORT WAYNE, Ind., Feb. 16, 2021 (GLOBE NEWSWIRE) — Franklin Electric Co. Inc. today announced fourth quarter and full year financial results for fiscal year 2020.Fourth quarter 2020...

Continue reading

GBS Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

– December 2020 Initial Public Offering generated $21.6m in gross proceeds andlisting on the NASDAQ Stock Market-Executes Partnerships, Research Collaboration and Commercial Agreements-– John Hopkins University, Wyss Institute & Cambridge Consultants Ltd.NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) — GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care, today announced its financial results for the fourth quarter and full year 2020 and provided a corporate update.“In part to the COVID-19 pandemic, diagnostics solutions have become of paramount importance in the clinical care continuum and accelerated the need for alternatives to the central laboratory testing model. 2020 has certainly been...

Continue reading

IPG Photonics Announces Fourth Quarter 2020 Financial Results

Company Ends 2020 with Year-Over-Year Growth in Sales and Strong BookingsEPS of $0.92 Reduced by Additional Inventory Charge of $0.20 and Foreign Exchange Loss of $0.07OXFORD, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the fourth quarter ended December 31, 2020.NM – Not meaningfulManagement Comments“We are very pleased with our fourth quarter results as we delivered revenue that was 10% higher than the fourth quarter 2019 and was above the top end of our guidance range,” said Dr. Valentin Gapontsev, IPG Photonics’ Chief Executive Officer. “In addition, book-to-bill was above one in the fourth quarter as we saw the traction in order flow continue from the third quarter. We are benefiting from the advantages of our leading-edge...

Continue reading

Fonar Announces 2nd Quarter and Six Months Financial Results for Fiscal 2021

The 38th HMCA-managed MRI scanner recently became operational at the White Plains, New York scanning center.The COVID-19 pandemic continues to be a hindrance to business. Total Revenues-Net decreased by 2% to $42.1 million for the six months ended December 31, 2020, versus corresponding six months one year earlier.Net Income for the six months ended December 31, 2020 decreased 18% to $7.2 million, versus corresponding six months one year earlier.Net Income for the quarter ended December 31, 2020 was $3.9 million, which was an increase of 21% over the preceding quarter ended September 30, 2020.Cash and cash equivalents and short-term investments increased 10% to $40.6 million at December 31, 2020, versus the fiscal year ended June 30, 2020.FONAR’s Book Value is $20.00 per common share.MELVILLE, N.Y., Feb. 16, 2021 (GLOBE NEWSWIRE) —...

Continue reading

Chart Industries Acquires Cryo Technologies

ATLANTA, Feb. 16, 2021 (GLOBE NEWSWIRE) — Chart Industries, Inc. (“Chart”) (NYSE: GTLS) today announced the acquisition of Cryogenic Gas Technologies, Inc. (“Cryo Technologies” or CT”) for $55 million in cash (subject to certain customary adjustments). Cryo Technologies is a global leader in custom engineered process systems to separate, purify, refrigerate, liquefy and distribute high value industrial gases such as hydrogen, helium, argon and hydrocarbons with design capabilities for cold boxes for hydrogen and helium use. The distribution systems Cryo Technologies supplies are located within the helium and hydrogen liquefaction facilities and are inclusive of trailer loading systems, which facilitates the first step in product distribution.CT Founder and President Rick Hessinger, along with the entire highly skilled CT team (270...

Continue reading

HCI Group Sets Fourth Quarter and Full Year 2020 Earnings Call for Thursday, March 11, 2021 at 4:45 p.m. ET

TAMPA, Fla., Feb. 16, 2021 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), an InsurTech company with operations in insurance, software development and real estate, will hold a conference call on Thursday, March 11, 2021, at 4:45 p.m. Eastern time to discuss results for the fourth quarter and full year ended December 31, 2020. Financial results will be issued in a press release after the close of the market on the same day.HCI management will host the presentation, followed by a question-and-answer period.Interested parties can listen to the live presentation by dialing the listen-only number below or by clicking the webcast link available on the Investor Information section of the company’s website at www.hcigroup.com.Date: Thursday, March 11, 2021Time: 4:45 p.m. Eastern time (1:45 p.m. Pacific time)Listen-only toll-free number:...

Continue reading

Eyenovia to Host Key Opinion Leader Webinar on Presbyopia

NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) — Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that it will host a Key Opinion Leader (KOL) webinar, entitled: “Presbyopia in Focus: Unlocking one of the Biggest Market Opportunities in Ophthalmology,” on Monday, February 22, 2021 at 1:00pm Eastern Time.The event will feature a fireside chat with KOL David F. Chang, M.D., past-president of the American Society of Cataract and Refractive Surgery (ASCRS), and Sean Ianchulev, M.D. M.P.H., Chief Executive Officer of Eyenovia and Professor of Ophthalmology, who will discuss various topics related to presbyopia and the potential benefits of treating patients with Eyenovia’s MicroLine formulation technology.Presbyopia...

Continue reading

Allo Technology’s Nationwide Open Optical Network Leverages Infinera’s GX Series

SUNNYVALE, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) and Allo Technology Sdn Bhd (Allo), a wholly owned subsidiary of Tenaga Nasional Berhad (TNB), announced today the deployment of Infinera’s industry-leading GX Series Compact Modular Platform over Allo’s nationwide open optical network infrastructure.Allo’s modernized open optical network enables the advancement of technology and connectivity services in Malaysia by providing the infrastructure needed, including tower fiberisation, data center connectivity, and cross-border connectivity to neighboring countries through Allo Carrier Network System (ACNS). Allo supports Malaysia’s digital transformation with its expanded offerings, which include connectivity services for residential and business enterprises.The selection of the GX Series solution supports...

Continue reading

PMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory Board

CRANBURY, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced the appointment of Guillermina (Gigi) Lozano, Ph.D., to its Scientific Advisory Board (SAB).“Gigi’s work in p53 biology has had a tremendous impact on our fundamental understanding of the p53 pathway and the consequences of p53 mutations in cancer,” said David Mack, Ph.D., President and Chief Executive Officer of PMV Pharma. “We welcome Gigi and look forward to her participation on our SAB.”Dr. Guillermina (Gigi) Lozano is a geneticist recognized for her studies of the p53 tumor suppressor pathway, from characterizing p53 as a transcriptional activator to characterizing the physiological...

Continue reading

CPI Aero Receives $8.7 Million Purchase Order From U.S. Air Force for T-38 Aircraft Modification Kits

– Increases Funded Orders Under Previously Awarded Multi-year Contract to $24.0 million –EDGEWOOD, N.Y., Feb. 16, 2021 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (CPI Aero®) (NYSE American: CVU) today announced that it has been awarded a $8.7 million purchase order under a previously announced contract from the U.S. Air Force (the “Air Force”) to provide structural modification kits, program management, logistics, and other sustainment services in support of Phase 3 of the T-38C Pacer Classic III Fuselage Structural Modification Kit Integration program (“PCIII”) and the Talon Repair Inspection and Maintenance (“TRIM”) program. In July 2019, the Company announced the PCIII and TRIM contract valued at up to $65.7 million.   The new purchase order brings the total funded value of the contract to $24.0 million and extends...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.